SK-2407/SN-001
DRPLA (Dentatorubral-pallidoluysian atrophy)
Preclinical/Co-developmentActive - Co-development with Nissan Chemical
Key Facts
Indication
DRPLA (Dentatorubral-pallidoluysian atrophy)
Phase
Preclinical/Co-development
Status
Active - Co-development with Nissan Chemical
Company
About Sanwa Kagaku Kenkyusho
Japanese pharmaceutical company developing novel treatments for metabolic and orphan diseases, with a lead candidate for acromegaly.
View full company profile